abstract |
The present invention relates to a process for the preparation of 5 - [[4 - [(2,3-dimethyl-2H-indazol-6-yl) methylamino] -2- pyrimidinyl] amino] -2- ≪ / RTI > sulfonamide, or a pharmaceutically acceptable salt thereof, and related oral suspensions. |